Differing perceptions of asthma control and treatment effectiveness by patients with severe asthma and treating subspecialists in the United States

• DOI: 10.1080/02770903.2021.1963766
• Publication Date: 2021-08-10T16:05:28Z
• Authors: Reynold A. Panett...; Bradley E. Chipps; Wendy C. Moore; Weily Soong; Warner W. Carr; James L. Kreindler; Sean O’Quinn; Frank Trudo; Christopher S. Am...
• Keywords: Biological Products; 03 medical and health sciences; Treatment Outcome; 0302 clinical medicine; Surveys and Questionnaires; Humans; Longitudinal Studies; Asthma; United States; 3. Good health

Objective For patients with severe asthma (SA), overestimation of control may lead to poorer outcomes. The objective this study was assess concurrent patient and specialist assessments treatment effectiveness among a large US cohort SA patients.Methods CHRONICLE is an ongoing observational treated by subspecialists. Asthma assessed using the patient-completed Control Test™ (ACT™) clinical assessment control. Treatment measured Global Evaluation Effectiveness (GETE) completed specialists.Results 1109 who online surveys at enrollment were included. 14%, 28%, 25%, 33% had ACT™ scores 5–9, 10–15, 16–19, 20–25, respectively. Compared 67% uncontrolled ACT™, 44% assessment. 54% according rated as controlled specialists, demonstrating Based on score, more frequent biologics compared other treatments. Using GETE, 90% reported 71% specialists. Patient categorizations agreed 73% time.Conclusion Specialists commonly overestimated relative scores. Patients frequently than These findings emphasize importance validated instruments reduce potential gaps associated patient-specialist discordance.Clinical trial registration ClinicalTrials.gov Identifier: NCT03373045.